NOGUCHI: For people who struggle with disordered eating, GLP-1 drugs can be a complicating factor
Antipsychotic-like effect of GLP-1 agonist liraglutide but not DPP-IV inhibitor sitagliptin in mouse model for psychosis
Moreover, the fourth, fifth, and sixth groups were fed on a diet containing 12% fat, with l-carnitine concentrations of 0, 0.5, and 1 g/kg diet, respectively termed F12Car0, F12Car0.5, and F12Car1
Temporary fluid retention or mild joint discomfort during extended protocols
at doses of 20 mg/kg21 and 10 mg/kg22 for 7 days, respectively
Eligibility depends on many factors, including: Medical history and medications Current health conditions Individual health goals Thats why conversations about GLP-1s are best had with a primary care clinician who knows your full health picture